Universitätsklinikum Frankfurt am Main (KGU)

Creativity and transition to bipolar disorder: a prospective analysis from the early-bipolife study (2026) Michaelis E, Bauer M, Bechdolf A, Bermpohl F, Berndt C, Bröckel-Bundt KL, Burkhardt E, et al. Journal article Advancing the prediction of factors associated with bipolar disorder risk: utilizing early recognition tools and polygenic risk scores (2026) Biere S, Matura S, Petrova K, Streit F, Chiocchetti AG, Ahrens KF, Schenk C, et al. Journal article Tumor mutations predict HER2-targeted therapy resistance in primary HER2-positive breast cancer (2026) Van Mackelenbergh MT, Pfarr N, Weber K, Untch M, Solbach C, Schneeweiss A, Jank P, et al. Journal article Functional outcomes and masticatory muscle thickness changes following temporomandibular joint surgery: A prospective cohort study (2026) Szikszay N, Pitak-Arnnop P, Landes CA Journal article Reassessing the role of CEA in the treatment of rectal cancer in the era of TNT (2026) Diefenhardt M, Hofheinz RD, Fleischmann M, Schlenska-Lange A, Grützmann R, Kirste S, Kuhnt T, et al. Journal article Contribution of depressive symptom load on prediction of transition to bipolar disorders: Results from the prospective-longitudinal multi-method Early-BipoLife study (2026) Petersen T, Martini J, Bauer M, Bechdolf A, Bermpohl F, Berndt C, Bröckel-Bundt KL, et al. Journal article Updated S3 guideline on ulcerative colitis Aktualisierte S3-Leitlinie Colitis ulcerosa (Version 7.0) (2026) Blumenstein I, Schnoy E, Atreya R, Bettenworth D, de Laffolie J, Kaltz B, Kienle P, et al. Journal article Meet NUM-ENRICH: A Collaborative National Effort to Extend and Harmonize Research Infrastructures Within the German Network University Medicine (2026) Waltemath D, Frodl E, Anton G, Beyan O, Boor P, Bucher A, Dietz J, et al. Journal article Clinical and treatment-related predictors of complete response after total neoadjuvant therapy for rectal cancer in a large multicenter analysis (2026) Wurschi GW, Schneider M, Becker JN, Frerker B, Vorbach SM, Ehret F, Diefenhardt M, et al. Journal article Feasibility and safety of nintedanib in combination with nivolumab in pretreated patients with advanced or metastatic adenocarcinoma of the lung – An AIO phase Ib/II trial (2026) Reck M, Waller C, Sadjadian P, Kambartel K, Grohé C, Sendler A, Reinmuth N, et al. Journal article